GAYNOR RICHARD
Insider CIK 1741284 · INFI Director · ALKS Director · NTGN President of R&D · ZLAB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab Ltd | P Buy | 2026-07-01 | 2026-07-06 | 1,736 | $19.05 | $33.1K | 80,737 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2026-06-17 | 2026-06-22 | 22,371 | — | $0 | 79,001 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2026-05-21 | 2026-05-22 | 6,142 | — | $0 | 37,226 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2026-05-21 | 2026-05-22 | 1,475 | $36.95 | $54.5K | 35,751 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-05-20 | 2026-05-22 | 5,409 | — | $0 | 5,409 | SEC↗ |
| ZLAB Zai Lab Ltd | P Buy | 2026-03-17 | 2026-03-19 | 1,731 | $18.91 | $32.7K | 56,630 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2025-06-18 | 2025-06-23 | 10,831 | — | $0 | 54,899 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2025-05-31 | 2025-06-02 | 8,013 | — | $0 | 33,008 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2025-05-31 | 2025-06-02 | 1,924 | $30.61 | $58.9K | 31,084 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2025-05-21 | 2025-05-23 | 6,142 | — | $0 | 6,142 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2025-05-21 | 2025-05-23 | 13,474 | — | $0 | 13,474 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2025-03-05 | 2025-03-06 | 2,500 | $35.07 | $87.7K | 44,068 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2024-09-03 | 2024-09-05 | 2,500 | $19.50 | $48.8K | 46,568 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2024-06-29 | 2024-07-01 | 6,104 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2024-06-29 | 2024-07-01 | 6,104 | — | $0 | 26,460 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2024-06-29 | 2024-07-01 | 1,465 | $24.10 | $35.3K | 24,995 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2024-06-18 | 2024-06-20 | 21,253 | — | $0 | 49,068 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2024-05-31 | 2024-06-04 | 17,492 | — | $0 | 17,492 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2024-05-31 | 2024-06-04 | 8,013 | — | $0 | 8,013 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 1,236 | $20.81 | $25.7K | 63,036 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 313 | $24.24 | $7.6K | 15,990 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 230 | $18.45 | $4.2K | 11,739 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 256 | $16.52 | $4.2K | 13,079 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 224 | $20.81 | $4.7K | 11,424 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 231 | $30.86 | $7.1K | 11,785 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 119 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-06-04 | 254 | $30.72 | $7.8K | 12,986 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-07-07 | 2023-07-10 | 5,957 | — | $0 | 21,786 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2023-07-07 | 2023-07-10 | 1,430 | $29.88 | $42.7K | 20,356 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 5,985 | — | $0 | 5,985 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-06-29 | 2023-06-30 | 12,732 | — | $0 | 12,732 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2023-06-29 | 2023-06-30 | 18,903 | $26.45 | $500.0K | 27,815 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 11,554 | — | $0 | 11,554 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-07-07 | 2022-07-08 | 5,957 | — | $0 | 5,957 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2022-06-14 | 2022-06-16 | 695 | $27.19 | $18.9K | 15,829 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-06-14 | 2022-06-16 | 7,585 | — | $0 | 16,524 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-12-02 | 2021-12-03 | 5,578 | — | $0 | 10,278 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-12-02 | 2021-12-03 | 1,339 | $22.11 | $29.6K | 8,939 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2021-11-19 | 2021-11-22 | 8,912 | — | $0 | 8,912 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 15,677 | — | $0 | 15,677 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-06-14 | 2021-06-16 | 7,585 | — | $0 | 7,585 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2021-06-10 | 2021-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-20 | 2021-05-21 | 6,104 | — | $0 | 6,104 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-05-20 | 2021-05-21 | 1,404 | $21.92 | $30.8K | 4,700 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 5,578 | — | $0 | 5,578 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-12-02 | 2020-12-04 | 11,509 | — | $0 | 11,509 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 12,823 | — | $0 | 12,823 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-05-20 | 2020-05-22 | 6,104 | — | $0 | 6,104 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 58,005 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 105,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 155,373 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer | 2020-05-06 | 2020-05-06 | 210,410 | — | $0 | 0 | SEC↗ |
| INFI INFINITY PHARMACEUTICALS, | A Award deriv | 2020-03-16 | 2020-03-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-29 | 2020-03-02 | 5,625 | $1.50 | $8.4K | 210,410 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | F Tax w/h | 2020-02-25 | 2020-02-27 | 5,465 | $1.51 | $8.3K | 216,035 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2020-01-12 | 2020-01-13 | 65,000 | — | $0 | 221,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-12-04 | 2019-12-09 | 11,200 | — | $0 | 11,200 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-12-04 | 2019-12-09 | 61,800 | — | $0 | 61,800 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | S Sale | 2019-11-27 | 2019-11-27 | 22,322 | $1.24 | $27.7K | 156,500 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | S Sale | 2019-11-26 | 2019-11-27 | 23,000 | $1.31 | $30.1K | 178,822 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-11-25 | 2019-11-25 | 75,000 | — | $0 | 221,822 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | S Sale | 2019-11-25 | 2019-11-27 | 20,000 | $1.37 | $27.4K | 201,822 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award | 2019-02-27 | 2019-03-01 | 57,500 | — | $0 | 146,822 | SEC↗ |